Although, in the present investigation, an increase in CLEC3B or soluble tetranectin in the HDL of BC was observed, it is reported a reduction in serum concentrations of CLEC3B in patients with BC [32,33,34,35,36] and elevated serum concentrations indicated a more favorable prognosis. The gene discussed is CLEC3B; the disease is breast cancer.